Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Repare Therapeutics is a clinical-stage precision oncology company focused on discovering and developing novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations. The company utilizes its proprietary, genome-wide, CRISPR-enabled screening platform, SNIPRx®, to systematically identify and validate novel Δενε Damage Response (DDR) targets and develop small molecule inhibitors. Repare's pipeline includes multiple drug candidates aimed at treating various cancers by exploiting the concept of synthetic lethality.
Serves as the principal executive office, housing corporate leadership, administrative functions, and key research and development operations.
The Montreal facility is equipped with modern laboratory spaces designed to support cutting-edge drug discovery and development in precision oncology.
The work culture emphasizes innovation, collaboration, scientific rigor, and a patient-centric approach to developing new cancer treatments.
Montreal offers a rich ecosystem of academic research institutions, a skilled talent pool in biotechnology, and supportive government initiatives for life sciences companies.
Repare Therapeutics has a significant presence in North America with its headquarters in Montreal, Canada, and a major research and operational site in Cambridge, MA, USA. These locations support global clinical trial activities, research collaborations, and strategic partnerships essential for advancing their pipeline of precision oncology therapeutics worldwide.
7210 Frederick-Banting, Suite 100
Montreal
Quebec
Canada
Address: 101 Main Street, Suite 2000, Cambridge, MA 02142, USA
To tap into the world-renowned talent pool, academic collaborations, and venture capital presence in one of the world's leading biotechnology clusters, facilitating U.S. based clinical trials and operations.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Repare Therapeutics' leadership includes:
Repare Therapeutics has been backed by several prominent investors over the years, including:
In the past 12 months, Repare Therapeutics notably strengthened its commercial leadership with a key executive hire.
Discover the tools Repare Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Repare Therapeutics commonly uses the email format combining the first initial and last name of an employee.
[first_initial][last]@reparerx.com
Format
jdoe@reparerx.com
Example
85%
Success rate
GlobeNewswire • May 7, 2024
Repare reported its Q1 2024 financial results, highlighting progress in its clinical programs, including camonsertib and lunresertib, and outlining upcoming milestones....more
GlobeNewswire • April 8, 2024
Repare presented encouraging updated data from its Phase 1 MYTHIC trial, evaluating lunresertib in combination with camonsertib, showing promising anti-tumor activity in heavily pretreated patients with specific genetic alterations....more
GlobeNewswire • February 27, 2024
The company reported its Q4 and full-year 2023 financials, detailing advancements across its synthetic lethality-based pipeline and outlining strategic priorities for 2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Repare Therapeutics, are just a search away.